Companion Animal Veterinary Vaccines Global Market Report 2026
상품코드:1938647
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
반려동물용 수의용 백신 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 39억 4,000만 달러에서 2026년에는 41억 9,000만 달러로, CAGR 6.4%로 확대가 전망되고 있습니다. 지난 수년간의 성장 요인으로는 반려동물 사육두수 증가, 반려동물 전염병 확산, 동물병원 및 진료소 확대, 동물 백신 접종의 이점에 대한 인식 증가, 백신 유통의 콜드체인 개선 등을 꼽을 수 있습니다.
반려동물용 수의용 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 6.5%의 CAGR로 53억 8,000만 달러에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 반려동물의 인간화 추세 증가, 반려동물 헬스케어 비용 지출 확대, 백신 기술 발전, 도시 지역에서의 반려동물 사육 증가, 정부의 동물 보건 지원 정책 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 혼합백신 채택 증가, 예방적 반려동물 건강관리에 대한 관심 증가, 반려동물 백신 접종률 증가, 재조합 백신 및 DNA 기반 백신 확대, 경구 및 저침습적 백신 접종 경로에 대한 수요 증가 등을 꼽을 수 있습니다.
반려동물의 건강에 대한 지출 증가는 향후 수년간 반려동물용 수의학 백신 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물의 건강이란 개, 고양이, 새, 소형 포유류, 기타 가축화된 반려동물 등 동물의 전반적인 신체 상태와 건강 상태를 말합니다. 반려동물의 건강에 대한 지출 증가는 반려동물의 더 길고 건강한 삶을 위한 예방 의료와 고급 치료의 중요성에 대한 보호자들의 인식이 높아지면서 촉진되고 있습니다. 반려동물용 수의학 백신 시장은 질병 예방, 중증 질환 위험 감소, 장기적인 수의학 치료 비용 절감에 기여하는 필수 백신을 제공함으로써 반려동물 건강 지출 증가를 지원하고 반려동물의 종합적인 건강 증진에 더 많은 투자를 하도록 유도하고 있습니다. 예를 들어 미국 기관 'Pet Business Professor'가 발표한 보고서에 따르면 2025년 2월 기준 미국 반려동물 소유주들은 반려동물 관련 서비스에 약 134억 2,000만 달러를 지출했으며, 이는 2022년 123억 6,000만 달러에서 8.5% 증가한 수치입니다. 이는 그루밍, 펫 호텔, 케어 관련 서비스의 지속적인 성장을 반영한 것입니다. 따라서 반려동물의 건강에 대한 지출 증가가 반려동물용 수의학 백신 시장의 성장을 촉진하고 있습니다.
반려동물용 동물용 백신 시장에서 활동하는 주요 기업은 반려동물 예방접종 프로그램의 효과와 안전성을 높이기 위해 재조합 DNA 백신을 포함한 혁신적인 백신을 도입하는 데 주력하고 있습니다. 재조합 DNA 백신은 바이러스나 세균 등 병원체의 유전물질을 무해한 숙주생물(벡터)에 삽입하여 면역반응을 유도하는 방식으로 제조됩니다. 예를 들어 2024년 3월 스페인의 생명공학 기업 젠달 그룹은 스페인 국립연구위원회(CSIC)와 공동 개발하여개 리슈만병 예방을 목적으로 개발된 최초의 재조합 DNA 백신 '네오레이쉬'를 발표했습니다. 마드리드 반려동물 수의사협회 제41회 연례총회에서 공식 발표된 Neoleish는 리슈마니아 인판텀 기생충에 의한 감염 위험을 90% 이상 감소시키는 효능을 입증했습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Companion animal vaccines are substances designed to stimulate the production of antibodies and confer immunity against one or more diseases in pets, including dogs, birds, and cats. They serve not only to protect against diseases but also to enhance food digestion, boost immunity, promote weight gain, and generate high-quality meat for commercial purposes.
The primary types of companion animal veterinary vaccines are inactivated, live attenuated, recombinant, and other products. Recombinant vaccines are created using recombinant DNA technology, involving the insertion of DNA encoding an antigen (e.g., a bacterial surface protein) into bacterial or mammalian cells, expression of the antigen within these cells, and subsequent purification. These products can be administered through oral, parenteral, and other routes of administration and are distributed through various channels, including veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other distribution channels.
Tariffs have moderately impacted the companion animal veterinary vaccines market by increasing costs of imported biological raw materials, adjuvants, and specialized manufacturing equipment required for recombinant and inactivated vaccines. These effects are most pronounced in recombinant and combination vaccine segments, with Asia-Pacific and Latin America experiencing higher price sensitivity due to reliance on imports. Veterinary hospitals and clinics face cost pressures that may slow vaccine uptake in price-sensitive regions. However, tariffs are also encouraging local vaccine manufacturing, regional supply chain strengthening, and investments in domestic R&D capabilities, creating long-term market resilience.
The companion animal veterinary vaccines market research report is one of a series of new reports from The Business Research Company that provides companion animal veterinary vaccines market statistics, including companion animal veterinary vaccines industry global market size, regional shares, competitors with a companion animal veterinary vaccines market share, detailed companion animal veterinary vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal veterinary vaccines industry. This companion animal veterinary vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The companion animal veterinary vaccines market size has grown strongly in recent years. It will grow from $3.94 billion in 2025 to $4.19 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in companion animal population, increasing prevalence of infectious pet diseases, expansion of veterinary clinics and hospitals, rising awareness of animal vaccination benefits, improvements in cold chain vaccine distribution.
The companion animal veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $5.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing pet humanization trends, rising expenditure on pet healthcare, advancements in vaccine technology, growth in urban pet ownership, supportive government animal health initiatives. Major trends in the forecast period include rising adoption of combination vaccines, increasing focus on preventive pet healthcare, growth in vaccination coverage for companion animals, expansion of recombinant and dna-based vaccines, rising demand for oral and less invasive vaccination routes.
The growing expenditure on pet health is expected to drive the growth of the companion animal veterinary vaccines market in the coming years. Pet health refers to the overall physical condition and well-being of animals such as dogs, cats, birds, small mammals, and other domesticated pets. Increased spending on pet health is being fueled by greater awareness among pet owners regarding the importance of preventive care and advanced medical treatments to help pets live longer and healthier lives. The companion animal veterinary vaccines market supports this rise in pet health spending by offering essential vaccines that help prevent diseases, lower the risk of serious illnesses, and reduce long-term veterinary treatment costs, encouraging pet owners to invest more in their pets' overall well-being. For example, in February 2025, according to a report published by Pet Business Professor, a U.S.-based agency, pet owners in the United States spent approximately $13.42 billion on pet services, representing an 8.5% increase from $12.36 billion in 2022, reflecting continued growth in grooming, boarding, and care-related services. Therefore, increasing expenditure on pet health is driving the growth of the companion animal veterinary vaccines market.
Major companies operating in the companion animal veterinary vaccines market are focusing on launching innovative vaccines, including recombinant DNA vaccines, to enhance the effectiveness and safety of immunization programs for pets. A recombinant DNA vaccine is produced by inserting genetic material from a pathogen, such as a virus or bacterium, into a harmless carrier organism or vector to stimulate an immune response. For instance, in March 2024, Zendal Group, a Spain-based biotechnology company, introduced Neoleish, the first recombinant DNA vaccine developed specifically to prevent canine leishmaniasis, in collaboration with the Spanish National Research Council (CSIC). Officially unveiled at the XLI Annual Congress of the Madrid Association of Veterinarians of Companion Animals, Neoleish demonstrated more than 90% effectiveness in reducing the risk of infection caused by the Leishmania infantum parasite.
In June 2023, Mars Inc., a U.S.-based manufacturing company, acquired Heska Corp. for approximately $1.3 billion. This acquisition reinforced Mars Petcare's veterinary care capabilities and supported its strategic focus on advancing pet health solutions. Following the acquisition, Heska became part of Mars Petcare's science and diagnostics division, including Antech Diagnostics. The integration expanded access to advanced diagnostic technologies, enhanced diagnostic services for veterinary professionals and pet owners, and accelerated research and development efforts in veterinary healthcare. Heska Corp. is a U.S.-based veterinary services company that specializes in the development, manufacturing, and commercialization of advanced veterinary diagnostics and related vaccines for canine and feline health.
Major companies operating in the companion animal veterinary vaccines market are C.H. Boehringer Sohn AG & Co. KG, Heska Corp., Merck and Co. Inc., Elanco Animal Health, Zoetis Inc., Ceva Sante Animale SA, Vetoquinol SA, Hipra India Pvt Ltd, Bimeda Animal Health Limited, Nexvet Biopharma plc, Laboratorios Hipra SA, Dechra Pharmaceuticals PLC, CZ Veterinaria SA, Virbac, Boehringer Ingelheim Animal Health, Indian Immunologicals Limited, HIPRA SA, IDT Biologika GmbH, Ourofino Saude Animal, Zydus Animal Health, Meiji Seika Pharma Co Ltd, Parnell Pharmaceuticals, Kindred Biosciences Inc, Hester Biosciences Limited
North America was the largest region in the companion animal veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the companion animal veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The companion animal veterinary vaccine market consists of sales of toxoid vaccines, viral vector vaccines, messenger RNA vaccines, and conjugated vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Companion Animal Veterinary Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses companion animal veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for companion animal veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The companion animal veterinary vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Inactivated; Live Attenuated; Recombinant; Other Products
2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores; Other Distribution Channels
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Biotechnology, Genomics & Precision Medicine
4.2. Major Trends
4.2.1 Rising Adoption Of Combination Vaccines
4.2.2 Increasing Focus On Preventive Pet Healthcare
4.2.3 Growth In Vaccination Coverage For Companion Animals
4.2.4 Expansion Of Recombinant And Dna-Based Vaccines
4.2.5 Rising Demand For Oral And Less Invasive Vaccination Routes
5. Companion Animal Veterinary Vaccines Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Veterinary Clinics
5.3 Animal Shelters And Rescue Centers
5.4 Pet Owners
5.5 Veterinary Research Institutes
6. Companion Animal Veterinary Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Companion Animal Veterinary Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Companion Animal Veterinary Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Companion Animal Veterinary Vaccines Market Size, Comparisons And Growth Rate Analysis
7.3. Global Companion Animal Veterinary Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Companion Animal Veterinary Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Companion Animal Veterinary Vaccines Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inactivated, Live Attenuated, Recombinant, Other Products
9.2. Global Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Parenteral, Other Routes Of Administration
9.3. Global Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels
9.4. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Live Attenuated Canine Vaccines, Live Attenuated Feline Vaccines, Live Attenuated Vaccine Combinations
9.6. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Recombinant, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
DNA Vaccines, Subunit Vaccines, Toxoid Vaccines
10. Companion Animal Veterinary Vaccines Market Regional And Country Analysis
10.1. Global Companion Animal Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Companion Animal Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Companion Animal Veterinary Vaccines Market
12.1. China Companion Animal Veterinary Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Companion Animal Veterinary Vaccines Market
13.1. India Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Companion Animal Veterinary Vaccines Market
14.1. Japan Companion Animal Veterinary Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Companion Animal Veterinary Vaccines Market
15.1. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Companion Animal Veterinary Vaccines Market
16.1. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Companion Animal Veterinary Vaccines Market
17.1. South Korea Companion Animal Veterinary Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Companion Animal Veterinary Vaccines Market
19.1. South East Asia Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Companion Animal Veterinary Vaccines Market
20.1. Western Europe Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Companion Animal Veterinary Vaccines Market
21.1. UK Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Companion Animal Veterinary Vaccines Market
23.1. France Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24.1. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Companion Animal Veterinary Vaccines Market
26.1. Eastern Europe Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Companion Animal Veterinary Vaccines Market
27.1. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Companion Animal Veterinary Vaccines Market
28.1. North America Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Companion Animal Veterinary Vaccines Market
29.1. USA Companion Animal Veterinary Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Companion Animal Veterinary Vaccines Market
31.1. South America Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Companion Animal Veterinary Vaccines Market
32.1. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Companion Animal Veterinary Vaccines Market
33.1. Middle East Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Companion Animal Veterinary Vaccines Market
34.1. Africa Companion Animal Veterinary Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Companion Animal Veterinary Vaccines Market Regulatory and Investment Landscape
36. Companion Animal Veterinary Vaccines Market Competitive Landscape And Company Profiles
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Companion Animal Veterinary Vaccines Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Companion Animal Veterinary Vaccines Market Company Profiles
36.3.1. C.H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Heska Corp. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Companion Animal Veterinary Vaccines Market Other Major And Innovative Companies
Ceva Sante Animale SA, Vetoquinol SA, Hipra India Pvt Ltd, Bimeda Animal Health Limited, Nexvet Biopharma plc, Laboratorios Hipra SA, Dechra Pharmaceuticals PLC, CZ Veterinaria SA, Virbac, Boehringer Ingelheim Animal Health, Indian Immunologicals Limited, HIPRA SA, IDT Biologika GmbH, Ourofino Saude Animal, Zydus Animal Health
38. Global Companion Animal Veterinary Vaccines Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Companion Animal Veterinary Vaccines Market
40. Companion Animal Veterinary Vaccines Market High Potential Countries, Segments and Strategies
40.1 Companion Animal Veterinary Vaccines Market In 2030 - Countries Offering Most New Opportunities
40.2 Companion Animal Veterinary Vaccines Market In 2030 - Segments Offering Most New Opportunities
